Anatomic Pathology Market is expected to reach US$ 53.27 Billion by 2031

Instruments Segment to Bolster Anatomic Pathology Market Growth During 2023–2031

According to our new research study on "Anatomic Pathology Market Forecast to 2031 – Global Analysis – by Products and Services, Application, and End User," the market is expected to grow from US$ 30.22 billion in 2023 to US$ 53.27 billion by 2031; it is anticipated to record a CAGR of 7.3% from 2023 to 2031. The anatomic pathology market report emphasizes the trends prevalent in the global market, along with drivers and deterrents affecting its growth.

The increase in the prevalence of cancer and kidney diseases and the rise in the number of strategic initiatives are among the factors contributing to the growing anatomic pathology market size. However, the lack of skilled professionals and stringent government regulations hamper the market growth. Further, the integration of artificial intelligence and machine learning is expected to bring new anatomic pathology market trends in the coming years.

Anatomic Pathology Market Share, by Region, 2023 (%)

Source: The Insight Partners Analysis

Rise in Number of Strategic Initiatives Propel Anatomic Pathology Market Growth

Small and big companies operating in the anatomic pathology market are increasingly adopting various strategies such as geographic expansion, new product launches, and technological advancements to boost their revenues. A few recent developments in the anatomic pathology market are mentioned below:

• In May 2024, Quest Diagnostic and PathAI entered a multifaceted collaboration to accelerate the adoption of digital and AI pathology innovations to improve quality, speed, and efficiency in diagnosing cancer and other diseases. Under the terms of this definitive agreement, Quest will acquire select assets of PathAI Diagnostics, the business of PathAI that provides digital and anatomic pathology laboratory services.
• In April 2024, Medline became the distributor of products of Epredia, a member of PHC Group. Epredia provides solutions for precision cancer diagnostics and tissue diagnostics in the anatomical pathology field. Through this agreement, Medline offers anatomical pathology products from Epredia to laboratories and customers, thus expanding Medline's extensive portfolio of lab products, devices, and equipment.
• In April 2024, StatLab Medical Products acquired Scientific Device Laboratory, a Chicago-based manufacturer of printed diagnostic slides and a variety of consumables and kits for the anatomic pathology and microbiology markets.
• In March 2024, StatLab Medical Products acquired Poly Scientific R&D ("Poly Scientific"), a US-based manufacturer and supplier of high-quality pathology stains, reagents, tissue controls, and paraffin for anatomic pathology laboratories. Because of this acquisition, StatLab's core manufacturing capabilities, including tissue controls, were expanded, further improving its position as a manufacturer of anatomic pathology consumables while broadening its market presence.
• In February 2024, Hologic Inc received the US Food and Drug Administration (FDA) approval for Genius Digital Diagnostics System, a digital cytology system that delivers next-gen technology for pap testing. This product is set to launch in the US in 2024. Genius Digital Diagnostics System is already sold in Europe, Australia, and New Zealand.

Therefore, the rise in strategic initiatives by market players boosts the growth of the anatomic pathology market.

The anatomic pathology market analysis has been carried out by considering the following segments: products and services, application, end user, and geography. Based on products and services, the anatomic pathology market is segmented into instruments, consumables, and services. The services segment is further bifurcated into histopathology and cytopathology. The instruments segment is further divided into microtomes and cryostat, automatic stainers, tissue processors, and others. The instruments segment held the largest market share in 2023. The instruments that are used in anatomic pathology practices include basic pathology equipment such as microtome, a tool to cut extremely thin sections for materials such as bones, minerals, and teeth; an automatic slide stainer that highlights the structures in biological tissues and provides a more detailed look at the sample; biomedical specimen cabinets that are used as storage systems to organize the supply of laboratories; cooling plate; paraffin trimmer/dispenser; and slide dryer. Microtome is used as an alternative to electropolishing and ion milling. Tissue processing systems that are used in anatomic pathology include tissue embedding systems, tissue floating systems, tissue processors, and tissue water bath instruments. Apart from these, many more advanced and automated devices are used in anatomic pathology, which vary from process to process, depending upon the test to be performed for diagnosis. These machines are complex to handle, and thus, proper training is required to perform tasks as per the requirements of the planned experiments. The growing adoption of automation is expected to boost the market for anatomic pathology instruments during the forecast period.

By application, the market is segmented into disease diagnosis, drug discovery and development, and others. The disease diagnosis segment held the largest anatomic pathology market share in 2023. Anatomic pathology is majorly used for diagnosing various diseases, including tumors or cancers, kidney and liver diseases, autoimmune disorders, and infections. It assists in studying the effects of disease on the human body post-microscopic examination of tissues, cells, and other specimens. The anatomic pathology-based disease diagnostic services include cytopathology, electron microscopy, histopathology, immunopathology, and surgical pathology. The surge in the prevalence of various chronic diseases, such as cancer and kidney diseases, would encourage people to adopt these services, especially histopathology and cytopathology, in disease diagnosis.

Based on end user, the anatomic pathology market is divided into hospitals, research laboratories, diagnostic laboratories, and others. The hospitals segment held the largest anatomic pathology market share in 2023. Hospitals account for the largest share of the anatomic pathology market due to the increasing prevalence of chronic illnesses, which require advanced diagnostic tests and tools, long-term care, and regular monitoring. Anatomic pathology majorly involves necropsy, cytopathology, histopathology, immunopathology, and cytopathology techniques. All these fields are related to the diagnosis and treatment of severe chronic diseases such as heart disease, cancer, and tumors. Anatomic pathology is also used in the study of kidney and liver diseases, autoimmune disorders, and infections. An increase in the number of hospitals and critical care centers, along with a rise in government initiatives for improving healthcare services, is projected to fuel the use of anatomical pathology equipment and services in hospitals.

The geographic scope of the anatomic pathology market report includes the assessment of the market performance in North America (US, Canada, and Mexico), Europe (Spain, UK, Germany, France, Italy, and Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and Rest of Asia Pacific), the South & Central America (Brazil, Argentina, and Rest of South & Central America), and the Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa)

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com